Published Papers & Misc - INAJI Motoki

Division display  61 - 80 of about 167 ／  All the affair displays >>

  1. Hashimoto Satoka, Maeda Jun, Takuwa Hiroyuki, Takado Yuhei, Shimojo Masafumi, Inaji Motoki, Kumata Katsushi, Zhang Ming-Rong, Suhara Tetsuya, Maehara Taketoshi, Higuchi Makoto. Abnormal tryptophan metabolism and astrocyte functional failure in the pathology of epilepsy Journal of the Japan Epilepsy Society. 2019.09; 37 (2): 551.

  2. Tanaka Y., Miyasaka N., Hara S., Inaji M., Maehara T., Nariai T.. Changes in cerebral blood flow during pregnancy detected by arterial spin labeling MRI in healthy subjects and in the patients with moyamoya disease JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2019.07; 39 230.

  3. Hayashi S., Inaji M., Nariai T., Wagatsuma K., Sakata M., Ishii K., Maehara T.. Gap filling and rebinning algorithms for 3D PET data JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2019.07; 39 594.

  4. Inaji M., Hayashi S., Nariai T., Sakata M., Ishii K., Maehara T.. Adenosine A1 Receptor Imaging with [C-11]MPDX PET in mesial temporal lobe epilepsy patients JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2019.07; 39 547.

  5. Inaji M, Hayashi S, Nariai T, Sakata M, Ishii K, Maehara T. Adenosine A1 Receptor Imaging with [C-11]MPDX PET in mesial temporal lobe epilepsy patients JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2019.07; 39 547.

  6. Hayashi S, Inaji M, Nariai T, Wagatsuma K, Sakata M, Ishii K, Maehara T. Gap filling and rebinning algorithms for 3D PET data JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2019.07; 39 594.

  7. Tanaka Y, Miyasaka N, Hara S, Inaji M, Maehara T, Nariai T. Changes in cerebral blood flow during pregnancy detected by arterial spin labeling MRI in healthy subjects and in the patients with moyamoya disease JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2019.07; 39 230.

  8. Hara S, Hori M, Ueda R, Hagiwara A, Hayashi S, Inaji M, Tanaka Y, Maehara T, Ishii K, Aoki S, Nariai T. Intravoxel incoherent motion perfusion in patients with Moyamoya disease: comparison with 15O-gas positron emission tomography. Acta radiologica open. 2019.05; 8 (5): 2058460119846587. ( PubMed, DOI )

  9. Hashimoto Satoka, Inaji Motoki, Nariai Tadashi, Kobayashi Daisuke, Sanjo Nobuo, Yokota Takanori, Ishii Kenji, Maehara Taketoshi. Usefulness of [11C] Methionine PET in the Differentiation of Tumefactive Multiple Sclerosis from High Grade Astrocytoma Neurologia medico-chirurgica. 2019.05; 59 (5): 176-183. ( ichushi )

  10. Hashimoto Satoka, Inaji Motoki, Nariai Tadashi, Kobayashi Daisuke, Sanjo Nobuo, Yokota Takanori, Ishii Kenji, Taketoshi Maehara. Usefulness of [C-11] Methionine PET in the Differentiation of Tumefactive Multiple Sclerosis from High Grade Astrocytoma NEUROLOGIA MEDICO-CHIRURGICA. 2019.05; 59 (5): 176-183. ( PubMed, DOI )

  11. Hashimoto Satoka, Inaji Motoki, Nariai Tadashi, Kobayashi Daisuke, Sanjo Nobuo, Yokota Takanori, Ishii Kenji, Maehara Taketoshi. 高グレード星細胞腫とtumefactive multiple sclerosisを鑑別するための[11C]Methionine PETの有用性(Usefulness of [11C] Methionine PET in the Differentiation of Tumefactive Multiple Sclerosis from High Grade Astrocytoma) Neurologia medico-chirurgica. 2019.05; 59 (5): 176-183.

  12. Hara Shoko, Hori Masaaki, Ueda Ryo, Hayashi Shihori, Inaji Motoki, Tanaka Yoji, Maehara Taketoshi, Ishii Kenji, Aoki Shigeki, Nariai Tadashi. Unraveling Specific Brain Microstructural Damage in Moyamoya Disease Using Diffusion Magnetic Resonance Imaging and Positron Emission Tomography JOURNAL OF STROKE & CEREBROVASCULAR DISEASES. 2019.04; 28 (4): 1113-1125. ( PubMed, DOI )

  13. Yoshimura Yuri, Hara Keiko, Akaza Miho, Ohta Katsuya, Sumi Yuki, Inaji Motoki, Yanagisawa Eriko, Maehara Taketoshi. 血液学的生化学的パラメータに対する抗てんかん薬単剤療法の影響(Effects of antiepileptic monotherapy on hematological and biochemical parameters) Epilepsy & Seizure. 2019; 11 (1): 1-13. ( ichushi )

  14. Yoshimura Yuri, Hara Keiko, Akaza Miho, Ohta Katsuya, Sumi Yuki, Inaji Motoki, Yanagisawa Eriko, Maehara Taketoshi. 血液学的生化学的パラメータに対する抗てんかん薬単剤療法の影響(Effects of antiepileptic monotherapy on hematological and biochemical parameters) Epilepsy & Seizure. 2019; 11 (1): 1-13.

  15. Hara S, Hori M, Inaji M, Maehara T, Aoki S, Nariai T. Regression of White Matter Hyperintensity after Indirect Bypass Surgery in a Patient with Moyamoya Disease. Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine. 2018.12; 18 (4): 247-248. ( PubMed, DOI )

  16. Hara S, Hori M, Murata S, Ueda R, Tanaka Y, Inaji M, Maehara T, Aoki S, Nariai T. Microstructural Damage in Normal-Appearing Brain Parenchyma and Neurocognitive Dysfunction in Adult Moyamoya Disease. Stroke. 2018.10; 49 (10): 2504-2507. ( PubMed, DOI )

  17. Wagatsuma Kei, Oda Keiichi, Sakata Muneyuki, Inaji Motoki, Miwa Kenta, Sasaki Masayuki, Toyohara Jun, Ishii Kenji. Validation of scatter limitation correction to eliminate scatter correction error in oxygen-15 gas-inhalation positron emission tomography images NUCLEAR MEDICINE COMMUNICATIONS. 2018.10; 39 (10): 936-944. ( PubMed, DOI )

  18. Karakama Jun, Nariai Tadashi, Hara Shoko, Hayashi Shihori, Sumita Kazutaka, Inaji Motoki, Tanaka Yoji, Wagatsuma Kei, Ishii Kenji, Nemoto Shigeru, Maehara Taketoshi. Unique Angiographic Appearances of Moyamoya Disease Detected with 3-Dimensional Rotational Digital Subtraction Angiography Imaging Showing the Hemodynamic Status JOURNAL OF STROKE & CEREBROVASCULAR DISEASES. 2018.08; 27 (8): 2147-2157. ( PubMed, DOI )

  19. Nakano T, Tamura K, Tanaka Y, Inaji M, Hayashi S, Kobayashi D, Nariai T, Toyohara J, Ishii K, Maehara T. Usefulness of <sup>11</sup>C-Methionine Positron Emission Tomography for Monitoring of Treatment Response and Recurrence in a Glioblastoma Patient on Bevacizumab Therapy: A Case Report. Case reports in oncology. 2018.05; 11 (2): 442-449. ( PubMed, DOI )

  20. Shihori Hayashi, Motoki Inaji, Tadashi Nariai, Keiichi Oda, Muneyuki Sakata, Jun Toyohara, Kenji Ishii, Kiichi Ishiwata, Taketoshi Maehara. Increased Binding Potential of Brain Adenosine A1 Receptor in Chronic Stages of Patients with Diffuse Axonal Injury Measured with [1-methyl-11C] 8-dicyclopropylmethyl-1-methyl-3-propylxanthine Positron Emission Tomography Imaging. J. Neurotrauma. 2018.01; 35 (1): 25-31. ( PubMed, DOI )

< PREV - NEXT >

To the head of this page.▲